Prolonged treatment with oral and inhaled tulobuterol does not induce airways tachyphlaxis-Reference-Cited by-同舟云学术

Prolonged treatment with oral and inhaled tulobuterol does not induce airways tachyphlaxis

Published:1990-12 Issue:S1 Volume:168 Page:210-218
ISSN:0341-2040
Container-title:Lung
language:en
Short-container-title:Lung

Author:

Patel K. R.

Publisher

Springer Science and Business Media LLC

Subject

Pulmonary and Respiratory Medicine

Link

http://link.springer.com/content/pdf/10.1007/BF02718135.pdf

Reference7 articles.

1. Holgate ST, Baldwin CJ, Tattersfield AE (1977) Beta-adrenergic agonist resistance in normal human airways. Lancet 2:375–377

2. Conolly ME, Tashkin DP, Hui KK, Littner MR, Wolfe RN (1982) Selective subsensitization of beta-adrenergic receptors in central airways of asthmatic and normal subjects during long-term therapy with inhaled salbutamol. J Allergy Clin Immunol 70:423–431

3. Weber RW, Smith JA, Nelson HS (1982) Aerosolized terbutaline in asthmatics: development of subsensitivity with long-term administration. J Allergy Clin Immunol 70:417–422

4. Shiota K, Kuriharu N (1978) Double-blind trial ofo-chloro-alpha [tertbutyl (amino) methyl] benzyl alcohol hydrochloride (C-78) in patients with chronic obstructive pulmonary disease. Jpn J Clin Med 55:868–878

5. Patel KR (1985) Comparison of bronchodilator effect of tulobuterol and salbutamol aerosols in patients with asthma. Br J Clin Pharmacol 20:717–718

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Asthma and COPD: A Focus on β-Agonists – Past, Present and Future;Handbook of Experimental Pharmacology;2023

2. Near Fatal Asthma in an Inner City Population;American Journal of Therapeutics;2016-11

3. Characterization of monolithic matrix patch system containing tulobuterol;Archives of Pharmacal Research;2008-08

4. Clinical Efficacy of the Transdermal Tulobuterol Patch in Patients with Chronic Obstructive Pulmonary Disease: A Comparison with Slow-Release Theophylline;Internal Medicine;2008

5. Penetration Enhancement of β2-Selective Agonist, Tulobuterol, Across Hairless Mouse Skin;Journal of Korean Pharmaceutical Sciences;2003-06-20